| First Author | Tsuchiya T | Year | 2002 |
| Journal | Toxicol Pathol | Volume | 30 |
| Issue | 4 | Pages | 501-6 |
| PubMed ID | 12187941 | Mgi Jnum | J:135606 |
| Mgi Id | MGI:3794167 | Doi | 10.1080/01926230290105677 |
| Citation | Tsuchiya T, et al. (2002) Skeletal myopathy in transgenic mice carrying human prototype c-Ha-ras gene. Toxicol Pathol 30(4):501-6 |
| abstractText | Skeletal myopathy was found in almost all-transgenic mice carrying the human prototype c-Ha-ras gene (rasH2 mouse). Microscopically, variation of the muscle fiber size, centrally placed nuclei, regenerating fibers, and interstitial fibrosis were evident; hyalinization and necrosis were sometimes observed in the skeletal muscle (femoralis and pectoralis) of the rasH2 mice. Inflammatory changes in the skeletal muscle or abnormality of adjacent peripheral nerve were not observed. The features were essentially similar to those of muscular dystrophy. Although the severity was relatively mild compared to 34-week-old rasH2 mice, the skeletal myopathy was also observed in younger male (10 weeks of age) rasH2 mice. In nontransgenic littermates, skeletal myopathy was not observed. The mRNA of human c-Ha-ras product was detected in femoral muscle from the rasH2 mice by RT-PCR. In conclusion, these data suggest that skeletal myopathy is occurring in almost all rasH2 mice. Integration of c-Ha-ras gene is thought to be crucial to pathogenesis of skeletal myopathy in the rasH2 mice. Further characterization of the muscular lesion and its pathogenesis are needed to explore the possibility of rasH2 mouse becoming a new model for muscular dystrophy. |
